The effect of resveratrol in cardio-metabolic disorders during pregnancy and offspring outcomes: a review.
J Dev Orig Health Dis
; 14(1): 3-14, 2023 02.
Article
em En
| MEDLINE
| ID: mdl-35678161
ABSTRACT
Resveratrol supplementation during pregnancy and lactation has been associated with a reduced risk of maternal obesity, gestational diabetes mellitus , and preeclampsia. In addition, emerging evidence has shown that maternal resveratrol supplementation diminishes cardio-metabolic disorders in offspring, highlighting its role in modulating adaptative responses involving phenotypical plasticity. Therefore, it is reasonable to infer that administration of resveratrol during pregnancy and lactation periods could be considered an important nutritional intervention to decrease the risk of maternal and offspring cardio-metabolic disorders. To highlight these new insights, this literature review will summarize the understanding emerging from experimental and clinical studies about resveratrol supplementation and its capacity to prevent or minimize maternal and offspring cardio-metabolic disorders.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Diabetes Gestacional
Limite:
Female
/
Humans
/
Pregnancy
Idioma:
En
Revista:
J Dev Orig Health Dis
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Brasil